Geneos Wealth Management’s First Trust Mid Cap Core AlphaDEX Fund FNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $409K | Hold |
3,191
| – | – | 0.01% | 754 |
|
|
2025
Q4 | $402K | Sell |
3,191
-266
| -8% | -$33.3K | 0.01% | 729 |
|
|
2025
Q3 | $434K | Hold |
3,457
| – | – | 0.01% | 693 |
|
|
2025
Q2 | $397K | Sell |
3,457
-1,947
| -36% | -$211K | 0.01% | 779 |
|
|
2025
Q1 | $589K | Buy |
5,404
+3,756
| +228% | +$434K | 0.01% | 834 |
|
|
2024
Q4 | $191K | Buy |
1,648
+50
| +3% | +$5.99K | 0.01% | 858 |
|
|
2024
Q3 | $187K | Sell |
1,598
-54
| -3% | -$6.08K | 0.01% | 786 |
|
|
2024
Q2 | $179K | Hold |
1,652
| – | – | 0.01% | 731 |
|
|
2024
Q1 | $187K | Hold |
1,652
| – | – | 0.01% | 711 |
|
|
2023
Q4 | $173K | Sell |
1,652
-32
| -2% | -$3K | 0.01% | 708 |
|
|
2023
Q3 | $155K | Hold |
1,684
| – | – | 0.01% | 748 |
|
|
2023
Q2 | $162K | Buy |
1,684
+300
| +22% | +$27K | 0.01% | 729 |
|
|
2023
Q1 | $125K | Sell |
1,384
-107
| -7% | -$9.9K | 0.01% | 779 |
|
|
2022
Q4 | $131K | Sell |
1,491
-459
| -24% | -$40.5K | 0.01% | 761 |
|
|
2022
Q3 | $156K | Buy |
1,950
+67
| +4% | +$5.96K | 0.01% | 669 |
|
|
2022
Q2 | $159K | Buy |
1,883
+95
| +5% | +$8.73K | 0.01% | 835 |
|
|
2022
Q1 | $175K | Buy |
1,788
+235
| +15% | +$22.9K | 0.01% | 858 |
|
|
2021
Q4 | $159K | Buy |
1,553
+212
| +16% | +$21.7K | 0.01% | 966 |
|
|
2021
Q3 | $132K | Sell |
1,341
-211
| -14% | -$21K | 0.01% | 1047 |
|
|
2021
Q2 | $155K | Buy |
1,552
+7
| +0.5% | +$687 | 0.01% | 966 |
|
|
2021
Q1 | $151K | Buy |
1,545
+22
| +1% | +$2K | ﹤0.01% | 1098 |
|
|
2020
Q4 | $142K | Buy |
1,523
+307
| +25% | +$23.2K | 0.01% | 979 |
|
|
2020
Q3 | $78K | Sell |
1,216
-303
| -20% | -$19.9K | ﹤0.01% | 1052 |
|
|
2020
Q2 | $91K | Buy |
1,519
+82
| +6% | +$4.69K | 0.01% | 961 |
|
|
2020
Q1 | $69K | Sell |
1,437
-536
| -27% | -$34.7K | ﹤0.01% | 981 |
|
|
2019
Q4 | $143K | Buy |
1,973
+63
| +3% | +$4.4K | 0.01% | 813 |
|
|
2019
Q3 | $128K | Buy |
1,910
+2
| +0.1% | +$136 | 0.01% | 808 |
|
|
2019
Q2 | $131K | Buy |
1,908
+474
| +33% | +$32.2K | 0.01% | 812 |
|
|
2019
Q1 | $96K | Sell |
1,434
-281
| -16% | -$18.4K | 0.01% | 880 |
|
|
2018
Q4 | $98K | Buy |
1,715
+271
| +19% | +$17.3K | 0.01% | 839 |
|
|
2018
Q3 | $103K | Buy |
1,444
+1,353
| +1,487% | +$96.2K | 0.01% | 869 |
|
|
2018
Q2 | $6K | Sell |
91
-534
| -85% | -$36K | ﹤0.01% | 1870 |
|
|
2018
Q1 | $40K | Hold |
625
| – | – | ﹤0.01% | 1094 |
|
|
2017
Q4 | $41K | Hold |
625
| – | – | ﹤0.01% | 1084 |
|
|
2017
Q3 | $38K | Hold |
625
| – | – | ﹤0.01% | 1080 |
|
|
2017
Q2 | $36K | Sell |
625
-3
| -0.5% | -$176 | ﹤0.01% | 1055 |
|
|
2017
Q1 | $36K | Sell |
628
-4
| -0.6% | -$232 | ﹤0.01% | 1013 |
|
|
2016
Q4 | $35K | Hold |
632
| – | – | ﹤0.01% | 963 |
|
|
2016
Q3 | $33K | Sell |
632
-14
| -2% | -$735 | ﹤0.01% | 952 |
|
|
2016
Q2 | $32K | Sell |
646
-165
| -20% | -$8.25K | ﹤0.01% | 959 |
|
|
2016
Q1 | $40K | Buy |
+811
| New | +$37.1K | 0.01% | 866 |
|
Other funds holding FNX
TCTWM
Geneos Wealth Management's FNX Position: Q1 2026 in Review
Geneos Wealth Management held its First Trust Mid Cap Core AlphaDEX Fund (FNX) position steady in Q1 2026 at 3,191 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #754.
Geneos Wealth Management first reported a position in FNX in Q1 2016 and has held it in 41 quarters since. The position peaked at $589K in Q1 2025. 208 funds tracked by Wall St. Rank hold FNX as of Q1 2026.
- Geneos Wealth Management held 3,191 shares of First Trust Mid Cap Core AlphaDEX Fund worth $409K as of Q1 2026.
- Geneos Wealth Management left its First Trust Mid Cap Core AlphaDEX Fund share count unchanged in Q1 2026.
- First Trust Mid Cap Core AlphaDEX Fund made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #754 holding.
- Geneos Wealth Management first reported a position in First Trust Mid Cap Core AlphaDEX Fund in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's First Trust Mid Cap Core AlphaDEX Fund position peaked at $589K in Q1 2025.
- 208 funds tracked by Wall St. Rank held First Trust Mid Cap Core AlphaDEX Fund as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.